These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 33684562)

  • 21. Cycloserine-induced Stevens-Johnson syndrome in an AIDS patient with multidrug-resistant tuberculosis.
    Akula SK; Aruna AS; Johnson JE; Anderson DS
    Int J Tuberc Lung Dis; 1997 Apr; 1(2):187-90. PubMed ID: 9441086
    [TBL] [Abstract][Full Text] [Related]  

  • 22. d-Cycloserine Pharmacokinetics/Pharmacodynamics, Susceptibility, and Dosing Implications in Multidrug-resistant Tuberculosis: A Faustian Deal.
    Deshpande D; Alffenaar JC; Köser CU; Dheda K; Chapagain ML; Simbar N; Schön T; Sturkenboom MGG; McIlleron H; Lee PS; Koeuth T; Mpagama SG; Banu S; Foongladda S; Ogarkov O; Pholwat S; Houpt ER; Heysell SK; Gumbo T
    Clin Infect Dis; 2018 Nov; 67(suppl_3):S308-S316. PubMed ID: 30496460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids.
    Zhu M; Nix DE; Adam RD; Childs JM; Peloquin CA
    Pharmacotherapy; 2001 Aug; 21(8):891-7. PubMed ID: 11718495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cycloserine-induced encephalopathy: evidence on brain MRI.
    Kwon HM; Kim HK; Cho J; Hong YH; Nam H
    Eur J Neurol; 2008 Jul; 15(7):e60-1. PubMed ID: 18484995
    [No Abstract]   [Full Text] [Related]  

  • 25. Pharmacokinetics and safety of moxifloxacin in children with multidrug-resistant tuberculosis.
    Thee S; Garcia-Prats AJ; Draper HR; McIlleron HM; Wiesner L; Castel S; Schaaf HS; Hesseling AC
    Clin Infect Dis; 2015 Feb; 60(4):549-56. PubMed ID: 25362206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitubercular therapy-induced psychosis.
    Singanamala B; Saini L; Madaan P; Singh P; Vaidya PC; Sahu JK
    Neurology; 2019 Dec; 93(23):1012-1013. PubMed ID: 31792104
    [No Abstract]   [Full Text] [Related]  

  • 27. Making optimal use of available anti-tuberculosis drugs: first steps to investigate terizidone.
    Alffenaar JWC; Peloquin CA; Migliori GB
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):2. PubMed ID: 29297417
    [No Abstract]   [Full Text] [Related]  

  • 28. Cycloserine Induced Suicidal Tendencies and Kanamycin Induced Ototoxicity in Indian MDR-TB Patient: A Case Report.
    Jangra MS; Chhabra M
    Curr Drug Saf; 2018; 13(3):211-213. PubMed ID: 29866015
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
    Bhushan B; Chander R; Kajal NC; Ranga V; Gupta A; Bharti H
    Indian J Tuberc; 2014 Oct; 61(4):318-24. PubMed ID: 25675695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.
    Yew WW; Wong CF; Wong PC; Lee J; Chau CH
    Clin Infect Dis; 1993 Aug; 17(2):288-9. PubMed ID: 8399888
    [No Abstract]   [Full Text] [Related]  

  • 31. [Symptomatic psychoses during treatment with cycloserine].
    Pecotić M; Domac V
    Neuropsihijatrija; 1964; 12(1-4):147-52. PubMed ID: 16305168
    [No Abstract]   [Full Text] [Related]  

  • 32. Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.
    Mugusi S; Ngaimisi E; Janabi M; Mugusi F; Minzi O; Aris E; Bakari M; Bertilsson L; Burhenne J; Sandstrom E; Aklillu E
    Eur J Clin Pharmacol; 2018 Nov; 74(11):1405-1415. PubMed ID: 30003275
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of Cycloserine Efficacy in Treatment of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis in Beijing, China.
    Yu X; Zeng X; Shi W; Hu Y; Nie W; Chu N; Huang H
    Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29311073
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum concentrations of cycloserine and outcome of multidrug-resistant tuberculosis in Northern Taiwan.
    Hung WY; Yu MC; Chiang YC; Chang JH; Chiang CY; Chang CC; Chuang HC; Bai KJ
    Int J Tuberc Lung Dis; 2014 May; 18(5):601-6. PubMed ID: 24903799
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Irreversible neuropathy in extremely-drug resistant tuberculosis: An unfortunate clinical conundrum.
    Saroha D; Garg D; Singh AK; Dhamija RK
    Indian J Tuberc; 2020 Jul; 67(3):389-392. PubMed ID: 32825876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis.
    Tornheim JA; Udwadia ZF; Arora PR; Gajjar I; Gupte N; Sharma S; Karane M; Sawant N; Kharat N; Blum AJ; Shivakumar SVBY; Mullerpattan JB; Pinto LM; Ashavaid TF; Gupta A; Rodrigues C
    Eur Respir J; 2022 Mar; 59(3):. PubMed ID: 34949698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of linezolid in multidrug resistant tuberculosis (MDR-TB)--a report of ten cases.
    von der Lippe B; Sandven P; Brubakk O
    J Infect; 2006 Feb; 52(2):92-6. PubMed ID: 15907341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitive Ultra-performance Liquid Chromatography Tandem Mass Spectrometry Method for Determination of Cycloserine in Plasma for a Pharmacokinetics Study.
    Mulubwa M; Mugabo P
    J Chromatogr Sci; 2019 Jul; 57(6):560-564. PubMed ID: 30927010
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetics of moxifloxacin, cycloserine, p-aminosalicylic acid and kanamycin for the treatment of multi-drug-resistant tuberculosis.
    Chang MJ; Jin B; Chae JW; Yun HY; Kim ES; Lee YJ; Cho YJ; Yoon HI; Lee CT; Park KU; Song J; Lee JH; Park JS
    Int J Antimicrob Agents; 2017 Jun; 49(6):677-687. PubMed ID: 28408267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Ofloxacin-cycloserine-protionamide-INH combination against treatment refractory lung tuberculosis].
    Mühlberger F; Nturanye F; Nasbimana J; Portaels F
    Pneumologie; 1995 Feb; 49(2):72-6. PubMed ID: 7724506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.